Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,966 | 126 | 98.5% |
| Education | $29.99 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $642.92 | 42 | $0 (2021) |
| ABBVIE INC. | $201.67 | 12 | $0 (2024) |
| Amgen Inc. | $189.70 | 11 | $0 (2024) |
| Novo Nordisk Inc | $119.34 | 8 | $0 (2024) |
| PFIZER INC. | $89.34 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $86.14 | 5 | $0 (2024) |
| Abbott Laboratories | $77.41 | 4 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $76.13 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $69.33 | 5 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $63.16 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $254.53 | 16 | Novo Nordisk Inc ($50.72) |
| 2023 | $278.38 | 16 | Abbott Laboratories ($77.41) |
| 2022 | $197.36 | 12 | ABBVIE INC. ($94.11) |
| 2021 | $100.79 | 6 | Amgen Inc. ($38.24) |
| 2020 | $155.13 | 10 | Sunovion Pharmaceuticals Inc. ($80.93) |
| 2019 | $252.89 | 19 | Sunovion Pharmaceuticals Inc. ($174.36) |
| 2018 | $368.05 | 23 | Sunovion Pharmaceuticals Inc. ($213.74) |
| 2017 | $389.16 | 25 | Sunovion Pharmaceuticals Inc. ($162.12) |
All Payment Transactions
127 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: DIABETES | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Respiratory | ||||||
| 09/03/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: VACCINES | ||||||
| 08/21/2024 | Hologic Sales and Service, LLC | APTIMA (Device), THINPREP 2000 PROCESSOR | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Diagnostics | ||||||
| 08/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.43 | General |
| 06/18/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/14/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Diabetes | ||||||
| 05/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.34 | General |
| 05/07/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: VACCINES | ||||||
| 04/12/2024 | Organon Llc | JADA SYSTEM (Device) | Food and Beverage | In-kind items and services | $6.14 | General |
| Category: POSTPARTUM UTERINE HEMORRHAGING | ||||||
| 02/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Bone Health | ||||||
| 02/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Inflammation | ||||||
| 12/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Gastroenterology | ||||||
| 11/07/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: VACCINES | ||||||
| 09/27/2023 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: VACCINES | ||||||
| 09/20/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Diabetes Care | ||||||
| 09/20/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Diabetes Care | ||||||
| 07/18/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Diabetes Care | ||||||
| 06/29/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: NEUROSCIENCE | ||||||
| 06/01/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: VACCINES | ||||||
| 05/24/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 2,212 | 3,513 | $331,872 | $127,886 |
| 2022 | 41 | 2,742 | 4,224 | $340,455 | $134,158 |
| 2021 | 40 | 2,702 | 3,907 | $307,035 | $122,968 |
| 2020 | 43 | 2,819 | 4,257 | $329,476 | $132,021 |
All Medicare Procedures & Services
160 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 283 | 526 | $94,680 | $37,730 | 39.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 55 | 173 | $39,098 | $15,041 | 38.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 72 | 81 | $20,250 | $8,483 | 41.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 66 | $19,140 | $7,768 | 40.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 146 | $18,250 | $7,666 | 42.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 66 | 89 | $13,350 | $7,248 | 54.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 18 | 44 | $17,160 | $6,877 | 40.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 30 | 33 | $12,540 | $6,592 | 52.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 255 | 449 | $3,143 | $3,068 | 97.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 217 | 275 | $8,250 | $2,828 | 34.3% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 28 | 29 | $3,625 | $2,723 | 75.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 28 | 32 | $19,140 | $2,485 | 13.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 41 | 45 | $4,500 | $2,263 | 50.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 233 | 297 | $8,910 | $2,252 | 25.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 28 | $5,600 | $2,225 | 39.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 134 | 138 | $6,072 | $1,802 | 29.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 25 | $2,975 | $1,484 | 49.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 85 | 142 | $3,550 | $1,339 | 37.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $9,269 | $1,246 | 13.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 72 | $2,304 | $962.80 | 41.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 19 | 23 | $2,737 | $956.72 | 35.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 49 | 57 | $1,995 | $750.79 | 37.6% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 61 | 77 | $1,617 | $638.33 | 39.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 11 | 11 | $1,100 | $602.40 | 54.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 49 | 90 | $1,350 | $496.68 | 36.8% |
About Dr. John Dunham, M.D
Dr. John Dunham, M.D is a Family Medicine healthcare provider based in Clarksville, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487624896.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Dunham, M.D has received a total of $1,996 in payments from pharmaceutical and medical device companies, with $254.53 received in 2024. These payments were reported across 127 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,966).
As a Medicare-enrolled provider, Dunham has provided services to 10,475 Medicare beneficiaries, totaling 15,901 services with total Medicare billing of $517,033. Data is available for 4 years (2020–2023), covering 160 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Clarksville, AR
- Active Since 01/26/2006
- Last Updated 07/09/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1487624896
Products in Payments
- BROVANA (Drug) $341.00
- VRAYLAR (Drug) $181.45
- UTIBRON (Drug) $177.68
- LONHALA MAGNAIR (Drug) $94.99
- Otezla (Drug) $81.51
- XIFAXAN (Drug) $71.98
- FARXIGA (Drug) $64.61
- ENTRESTO (Drug) $63.16
- FREESTYLE LIBRE 2 (Device) $58.61
- SHINGRIX (Biological) $56.24
- Prolia (Biological) $52.26
- QULIPTA (Drug) $50.04
- JARDIANCE (Drug) $49.77
- PREVNAR 20 (Biological) $49.37
- Ozempic (Drug) $47.11
- XARELTO (Drug) $38.15
- INVOKANA (Drug) $31.18
- Yupelri (Drug) $28.96
- Victoza (Drug) $28.19
- BREZTRI (Drug) $21.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Clarksville
Patricia Isaacs, M.d, M.D
Family Medicine — Payments: $54,287
Dr. Carlo Pike, D.o, D.O
Family Medicine — Payments: $15,761
Dr. David Boles, Do, DO
Family Medicine — Payments: $15,467
Dr. Scott Kuykendall, M.d, M.D
Family Medicine — Payments: $11,968
Dr. William Williams, D.o, D.O
Family Medicine — Payments: $11,059
Roxanne Marshall, M.d, M.D
Family Medicine — Payments: $10,915